Prothena (NASDAQ:PRTA) PT Lowered to $24.00
Prothena (NASDAQ:PRTA – Free Report) had its price target reduced by Royal Bank of Canada from $28.00 to $24.00 in a report released on Friday, Benzinga reports. Royal Bank of Canada currently has a sector perform rating on the biotechnology company’s stock. A number of other equities analysts have also recently issued reports on the […]
More Stories
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have been given an average recommendation of “Moderate Buy” by...
Principal Financial Group, Inc. (NYSE:PFG) Receives Average Recommendation of “Hold” from Analysts
Shares of Principal Financial Group, Inc. (NYSE:PFG – Get Free Report) have received an average rating of “Hold” from the...
Insider Selling: Upwork Inc. (NASDAQ:UPWK) CEO Sells 20,000 Shares of Stock
Upwork Inc. (NASDAQ:UPWK – Get Free Report) CEO Hayden Brown sold 20,000 shares of the firm’s stock in a transaction...
SouthState Co. (NASDAQ:SSB) Insider Sells $250,000.00 in Stock
SouthState Co. (NASDAQ:SSB – Get Free Report) insider Daniel E. Bockhorst sold 2,500 shares of the business’s stock in a...
Citigroup Downgrades MKS Instruments (NASDAQ:MKSI) to Neutral
Citigroup cut shares of MKS Instruments (NASDAQ:MKSI – Free Report) from a buy rating to a neutral rating in a...
LKQ (NASDAQ:LKQ) Downgraded to Hold at StockNews.com
StockNews.com cut shares of LKQ (NASDAQ:LKQ – Free Report) from a buy rating to a hold rating in a research...